• 23 October 2017

    Social listening: A tactic to tackle anti-vaccine beliefs

    The negative perceptions of vaccines that are held by a small proportion of parents—specifically, a view that the potential risks of vaccination far outweigh any associated benefits—can contribute to outbreaks...

  • 18 October 2017

    Tenapanor likely to makes waves in IBS-C space

    On 11 October, Ardelyx reported positive results from a second pivotal Phase III trial (T3MPO-2) assessing the efficacy and safety of its lead product, tenapanor, which is under development for...